Neutrophil extracellular traps promote angiogenesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 10, 2016, Pages 2078-2087

  Aldabbous, Lulwah ^a   Abdul Salam, Vahitha ^a   Mckinnon, Tom ^b   Duluc, Lucie ^a   Pepke Zaba, Joanna ^b   Southwood, Mark ^b   Ainscough, Alexander J ^a   Hadinnapola, Charaka ^b   Wilkins, Martin R ^a   Toshner, Mark ^a   Wojciak Stothard, Beata ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

cell movement; endothelial cells; endothelin 1; extracellular traps; homeostasis; hypertension, pulmonary; neutrophils

Indexed keywords

DNA; ENDOTHELIN 1; GELATINASE B; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOCYTE ELASTASE; MATRIGEL; MYELOPEROXIDASE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE; CHLORIDE CHANNEL; CLIC4 PROTEIN, HUMAN; PEROXIDASE; TLR4 PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MOTILITY; CELL PROLIFERATION; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR TRAP; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PLASMA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SMOOTH MUSCLE CELL; THROMBUS; VASCULARIZATION; ANIMAL; CASE CONTROL STUDY; CELL CULTURE; CELL MOTION; COCULTURE; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PULMONARY ARTERY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHLORIDE CHANNELS; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; EXTRACELLULAR TRAPS; HUMANS; HYDROGEN PEROXIDE; HYPERTENSION, PULMONARY; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; NF-KAPPA B; PEROXIDASE; PULMONARY ARTERY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

EID: 84988615373     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307634     Document Type: Article

References (47)

1. Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol. 2007;5:577-582. doi: 10.1038/nrmicro1710.
2. Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349:316-320. doi: 10.1126/science.aaa8064.
3. Gupta AK, Hasler P, Holzgreve W, Hahn S. Neutrophil NETs: a novel contributor to preeclampsia-Associated placental hypoxia?. Semin Immunopathol. 2007;29:163-167. doi: 10.1007/s00281-007-0073-4.
4. Müller-Redetzky H. Targeting neutrophil extracellular traps in acute lung injury: a novel therapeutic approach in acute respiratory distress syndrome?. Anesthesiology. 2015;122:725-727. doi: 10.1097/ALN.0000000000000604.
5. Brill A, Fuchs TA, Savchenko AS, Thomas GM, Martinod K, De Meyer SF, Bhandari AA, Wagner DD. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost. 2012;10:136-144. doi: 10.1111/j.1538-7836.2011.04544.x.
6. Demers M, Wagner DD. Neutrophil extracellular traps: A new link to cancer-Associated thrombosis and potential implications for tumor progression. Oncoimmunology. 2013;2:e22946. doi: 10.4161/onci.22946.
7. Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med. 2011;17:1381-1390. doi: 10.1038/nm.2514.
8. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest. 2012;122:4306-4313. doi: 10.1172/JCI60658.
9. Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol. 2011;8:443-455. doi: 10.1038/nrcardio.2011.87.
10. Gupta AK, Hasler P, Holzgreve W, Gebhardt S, Hahn S. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol. 2005;66:1146-1154. doi: 10.1016/j.humimm.2005.11.003.
11. Quarck R, Nawrot T, Meyns B, Delcroix M. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;53:1211-1218. doi: 10.1016/j.jacc.2008.12.038.
12. Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22:146-153. doi: 10.1038/nm.4027.
13. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46:903-975. doi: 10.1183/13993003.01032-2015.
14. Jonigk D, Golpon H, Bockmeyer CL, et al. Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment. Am J Pathol. 2011;179:167-179. doi: 10.1016/j.ajpath.2011.03.040.
15. Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation. 2014;130:508-518. doi: 10.1161/CIRCULATIONAHA.114.009309.
16. Moser B, Megerle A, Bekos C, Janik S, Szerafin T, Birner P, Schiefer AI, Mildner M, Lang I, Skoro-Sajer N, Sadushi-Kolici R, Taghavi S, Klepetko W, Ankersmit HJ. Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. PLoS One. 2014;9:e106440. doi: 10.1371/journal.pone.0106440.
17. Hamaguchi S, Akeda Y, Yamamoto N, Seki M, Yamamoto K, Oishi K, Tomono K. Origin of circulating free DNA in sepsis: analysis of the CLP mouse model. Mediators Inflamm. 2015;2015:614518. doi: 10.1155/2015/614518.
18. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, Toy P, Werb Z, Looney MR. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest. 2012;122:2661-2671. doi: 10.1172/JCI61303.
19. Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM, Syro LV, Kovacs K, Lloyd RV. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res. 2011;31:2283-2290.
20. Churg A, Marshall CV, Sin DD, Bolton S, Zhou S, Thain K, Cadogan EB, Maltby J, Soars MG, Mallinder PR, Wright JL. Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185:34-43. doi: 10.1164/rccm.201103-0468OC.
21. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM, Brümmer J, Rudolph V, Münzel T, Heitzer T, Meinertz T, Baldus S. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A. 2005;102:431-436. doi: 10.1073/pnas.0405193102.
22. Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood. 2014;123:2768-2776. doi: 10.1182/blood-2013-10-463646.
23. Bauer EM, Shapiro R, Billiar TR, Bauer PM. High mobility group Box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4-And interferon response factor 3-dependent mechanism(s). J Biol Chem. 2013;288:1365-1373. doi: 10.1074/jbc.M112.434142.
24. Grote K, Schütt H, Schieffer B. Toll-like receptors in angiogenesis. ScientificWorldJournal. 2011;11:981-991. doi: 10.1100/tsw.2011.92.
25. Wojciak-Stothard B, Abdul-Salam VB, Lao KH, et al. Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension. Circulation. 2014;129:1770-1780. doi: 10.1161/CIRCULATIONAHA.113.006797.
26. Kolaczkowska E, Kubes P. Phagocytes & granulocytes. Angiogenic neutrophils: a novel subpopulation paradigm. Blood. 2012;120:4455-4457. doi: 10.1182/blood-2012-09-457226.
27. Cedervall J, Zhang Y, Huang H, Zhang L, Femel J, Dimberg A, Olsson AK. Neutrophil extracellular traps accumulate in peripheral blood vessels and compromise organ function in tumor-bearing animals. Cancer Res. 2015;75:2653-2662. doi: 10.1158/0008-5472.CAN-14-3299.
28. Radisavljevic Z, Avraham H, Avraham S. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J Biol Chem. 2000;275:20770-20774. doi: 10.1074/jbc.M002448200.
29. Wu Y, Ip JE, Huang J, Zhang L, Matsushita K, Liew CC, Pratt RE, Dzau VJ. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res. 2006;99:315-322. doi: 10.1161/01.RES.0000235986.35957.a3.
30. Abramovitch R, Neeman M, Reich R, Stein I, Keshet E, Abraham J, Solomon A, Marikovsky M. Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Lett. 1998;425:441-447.
31. Iwamoto R, Yamazaki S, Asakura M, Takashima S, Hasuwa H, Miyado K, Adachi S, Kitakaze M, Hashimoto K, Raab G, Nanba D, Higashiyama S, Hori M, Klagsbrun M, Mekada E. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci U S A. 2003;100:3221-3226. doi: 10.1073/pnas.0537588100.
32. Tazzyman S, Lewis CE, Murdoch C. Neutrophils: key mediators of tumour angiogenesis. Int J Exp Pathol. 2009;90:222-231. doi: 10.1111/j.1365-2613.2009.00641.x.
33. Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, Brinkmann V, Jungblut PR, Zychlinsky A. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009;5:e1000639. doi: 10.1371/journal.ppat.1000639.
34. Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, Lohmeyer J, Preissner KT. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One. 2012;7:e32366. doi: 10.1371/journal.pone.0032366.
35. Yasuda M, Shimizu S, Tokuyama S, Watanabe T, Kiuchi Y, Yamamoto T. A novel effect of polymorphonuclear leukocytes in the facilitation of angiogenesis. Life Sci. 2000;66:2113-2121.
36. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol. 2004;172:2522-2529.
37. Matsubara K, Nigami H, Harigaya H, Osaki M, Baba K. Myeloperoxidase antineutrophil cytoplasmic antibody positive vasculitis during propylthiouracil treatment: successful management with oral corticosteroids. Pediatr Int. 2000;42:170-173.
38. Mutoh A, Ueda S. Peroxidized unsaturated fatty acids stimulate Toll-like receptor 4 signaling in endothelial cells. Life Sci. 2013;92:984-992. doi: 10.1016/j.lfs.2013.03.019.
39. Savchenko AS, Martinod K, Seidman MA, Wong SL, Borissoff JI, Piazza G, Libby P, Goldhaber SZ, Mitchell RN, Wagner DD. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost. 2014;12:860-870. doi: 10.1111/jth.12571.
40. Maragoudakis ME, Tsopanoglou NE, Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans. 2002;30:173-177. doi: 10.1042/.
41. ten Dijke P, Goumans MJ, Pardali E. Endoglin in angiogenesis and vascular diseases. Angiogenesis. 2008;11:79-89. doi: 10.1007/s10456-008-9101-9.
42. Salani D, Taraboletti G, Rosanò L, Di Castro V, Borsotti P, Giavazzi R, Bagnato A. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol. 2000;157:1703-1711. doi: 10.1016/S0002-9440(10)64807-9.
43. Soon E, Crosby A, Southwood M, Yang P, Tajsic T, Toshner M, Appleby S, Shanahan CM, Bloch KD, Pepke-Zaba J, Upton P, Morrell NW. Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension. Am J Respir Crit Care Med. 2015;192:859-872. doi: 10.1164/rccm.201408-1509OC.
44. Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, Resink TJ. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett. 2010;584:3193-3197. doi: 10.1016/j.febslet.2010.06.006.
45. Rose F, Hattar K, Gakisch S, Grimminger F, Olschewski H, Seeger W, Tschuschner A, Schermuly RT, Weissmann N, Hanze J, Sibelius U, Ghofrani HA. Increased neutrophil mediator release in patients with pulmonary hypertension-suppression by inhaled iloprost. Thromb Haemost. 2003;90:1141-1149. doi: 10.1160/TH03-03-0173.
46. Villanueva E, Yalavarthi S, Berthier CC, et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol. 2011;187:538-552. doi: 10.4049/jimmunol.1100450.
47. Wright HL, Moots RJ, Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10:593-601. doi: 10.1038/nrrheum.2014.80.